Prognosis
Regeneron Covid Drug to Roll Out in 30,000-Dose Shipment
This article is for subscribers only.
Thirty thousand doses of Regeneron Pharmaceuticals Inc.’s antibody cocktail will be shipped Tuesday, after the experimental coronavirus treatment got an emergency authorization from U.S. regulators.
Health and Human Services Secretary Alex Azar detailed plans to distribute the therapy at a news conference on Monday. The drug, called REGN-COV2, received clearance from the U.S. Food and Drug Administration for treatment of mild to moderate Covid-19 in adults and some children of at least 12 years of age.